Organ on Chip Market

Market Insights

Enhancing the viability of preclinical expectations of human drug reactions is critical to reducing expensive failures in clinical trials. The pharmaceutical industry is confronting phenomenal challenges attributable to increasing expenses and the declining efficiency of drug research and development. Late advances in microfabrication, cell biology, and microfluidics have empowered the improvement of micro-engineered models of the useful parts of the human body known as “organs on chips.”

Organs on a chip are micro-engineered biometric systems that imitate the main purpose of living organs. These micro-devices provide a more precise model than traditional cell culture for recreating composite cell-matrix and cell-cell collaborations. In this manner, they possibly represent a fascinating tool for chemical and pharmaceutical applications. They additionally permit contemplation of human physiology for a particular organ and, in this way, empower the improvement of the novel in vitro disease models. Several research activities have been conducted by different companies and research institutes to bring this advanced technology to the market. Currently, there are only a few companies involved in the development of organs on chips, but it is expected that the number of players will increase in the future.

The purpose of this research study titled “Organ on Chip Market: Growth, Future Prospects, and Competitive Analysis, 2018–2026” is to offer stakeholders, manufacturers, business representatives, and industry sponsors exhaustive exploration to allow them to take planned initiatives and resolutions aligned with the expectations in the global organ on the chip market. This report presents and assesses the chief scenarios in the overall organ-on-chip market and the market’s size and forecast.

This report classifies the worldwide organ-on-chip market in terms of products, end users, and geographical distribution. Based on product types, the global organ-on-chip market is classified into lungs on a chip, hearts on a chip, livers on a chip, kidneys on a chip, and others. The end users considered for the purpose of this study are research institutes and pharmaceutical manufacturers. Market size and forecasts for every cited division for the period from 2016 to 2026 are offered in the report, along with particular CAGRs for the forecast period from 2018 to 2026.

This report includes regional market divisions accompanied by leading countries, which are presented as follows:

• Europe

• • Germany
  • United Kingdom
  • Rest of Europe
• North America
  • Canada
  • United States
• Asia Pacific
  • Japan
  • China
  • Rest of Asia Pacific
• Middle East and Africa
  • GCC
  • Rest of the Middle East and Africa
• Latin America
  • Brazil
  • Mexico
  • rest of Latin America

This study covers a thorough depiction of the above-indicated market segments for the duration of 2016–2026.

An exhaustive investigation of market situations has been provided in the report to get a proper comprehension of the market and the associated trends. The report employs a number of tools to assess the level of competition among the leading market players. The study additionally contains company profiles of the market players with a prominent hold on the overall organ-on-chip market. Some of the foremost players in the global organ-on-chip market recorded in this study are Ascendance Biotechnology, CN Bio Innovations, Emulate, Inc., HREL Corporation, Insphero AG, MIMETAS B.V., Nortis Inc., TARA Biosystems, Inc., and TissUse GmbH.

For the purpose of this study, the global organ-on-chip market is studied for the following product types:

• Chip’s Lungs
• Chip has a heart.
• Liver in Chip
• Kidney on the Chip
• Others

The cumulative burden of growing incidences of heart and kidney-related disorders will help drive the organ chip market. Lungs on a Chip dominated the market in 2017, and it is anticipated to continue its supremacy in the forecast period of 2018–2026. The “heart on chip” segment has a higher potential for growth as it is the fastest-growing market. The organ-on-chip market will experience an impressive growth rate, mostly due to a surge in the aging population, growth in the number of patients suffering from lung and heart diseases, and the growing need for new technologies to be used as novel tools in drug discovery and development. Amplified skills and consciousness have also resulted in the growing acceptance of novel and enhanced technologies by physicians for disease diagnosis. The rapid evolution of the healthcare sector and technological advancements are thus selected drivers for the growth of the global organ-on-chip market.

The global organ-on-chip market is being studied for its application in the following usage areas for the purposes of this study:

• Research Institutes
• Pharmaceutical Manufacturers

Among the considered usage areas, organ-on-chip technology enjoys the largest application in research institutes, followed by pharmaceutical manufacturers. Higher affordability of research institutes for the uptake of organs on chips, greater handling skills, and new drug discovery are the foremost factors driving the organ-on-chip market in research institutes. It is further anticipated that the growing preference for early drug testing results and the need for more reliable data will enhance the demand for organs on the chip during the forecast period. Therefore, it is predictable that the growth of the research institute sector will be greater than the global benchmark during the forecast period.

Geographically, the global organ-on-chip market is composed of Latin America, the Middle East, Africa, Europe, Asia Pacific, and North America.

North America holds the major share in the global organ-on-chip market, followed by Europe. Major reasons for the incumbent status of these regions are they’re being early adopters of new advanced technologies, their huge consumer base, and their higher organ transplant rate. Furthermore, Asia Pacific is a lucrative market for the companies involved in the organ-on-chip market. Though widespread commercialization of this technology is not expected to happen in the early years, as the market is still in its initial stages in developed regions, it would take a couple of years before organizations could assume a return on investment. China and Japan are the main markets in the region. The need for advanced testing and research technologies and time-saving techniques will enhance the market growth in the future. During the forecast period of 2018 to 2026, Europe is seen as the fastest-growing region, followed by Asia Pacific.

The geographical classification of the global organ-on-chip market is as follows:

• Asia Pacific (Japan, China, and the Rest of Asia Pacific)
• North America (Canada and the United States)
• Middle East and Africa (GCC plus the rest of the Middle East and Africa)
• Europe (Germany, the U.K., and the Rest of Europe)
• Latin America (Mexico, Brazil, and the Rest of Latin America)

Chapter 1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Phase III-Expert Panel Review
1.3.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Organ on Chip Market Portraiture
2.1.1. Global Organ on Chip Market, by Product, 2017 (US$ Mn)
2.1.2. Global Organ on Chip Market, by End Users, 2017 (US$ Mn)
2.1.3. Global Organ on Chip Market, by Geography, 2017 (US$ Mn)

Chapter 3. Organ on Chip: Market Dynamics and Outlook
3.1. Market Definition and Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Top Three Countries
3.7. Competitive Landscape
3.7.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition, by Product, 2017
4.2. Lungs on Chip
4.3. Heart on Chip
4.4. Liver in Chip
4.5. Kidney on Chip
4.6. Others

Chapter 5. Global Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
5.1. Overview
5.1.1. Comparative Analysis, by End Users, 2017 vs. 2026 (Value %)
5.2. Research Institutes
5.3. Pharmaceutical Manufacturers

Chapter 6. Global Organ on Chip Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America Organ on Chip Market Analysis, 2016 – 2026 (US$ Mn)
6.2.1. North America Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
6.2.2. North America Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
6.2.3. North America Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Organ on Chip Market Analysis, 2016 – 2026 (US$ Mn)
6.3.1. Europe Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
6.3.2. Europe Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
6.3.3. Europe Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Organ on Chip Market Analysis, 2016 – 2026 (US$ Mn)
6.4.1. Asia Pacific Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of APAC
6.5. Latin America Organ on Chip Market Analysis, 2016 – 2026 (US$ Mn)
6.5.1. Latin America Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
6.5.2. Latin America Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
6.5.3. Latin America Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Organ on Chip Market Analysis, 2016 – 2026 (US$ Mn)
6.6.1. MEA Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
6.6.2. MEA Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
6.6.3. MEA Organ on Chip Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Ascendance Biotechnology
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. CN Bio Innovations
7.3. Emulate, Inc.
7.4. HµREL Corporation
7.5. Insphero AG
7.6. MIMETAS B.V.
7.7. Nortis Inc.
7.8. TARA Biosystems, Inc.
7.9. TissUse GmbH Pioneer Surgical Technology

List of Figures

FIG. 1 Organ on Chip: Market Segmentation
FIG. 2 Global Organ on Chip Market, by Product, 2017 (US$ Mn)
FIG. 3 Global Organ on Chip Market, by End Users, 2017 (US$ Mn)
FIG. 4 Global Organ on Chip Market, by Geography, 2017 (US$ Mn)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2017
FIG. 7 Global Lungs on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 8 Global Heart on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 9 Global Liver in Chip Market, 2016 – 2026 (US$ Mn)
FIG. 10 Global Kidney on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global Others Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 12 Global Organ on Chip in Research Institutes Market, 2016 – 2026 (US$ Mn)
FIG. 13 Global Organ on Chip in Pharmaceutical Manufacturers Market, 2016 – 2026 (US$ Mn)
FIG. 14 U.S. Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 15 Canada Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 16 U.K. Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 17 Germany Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 18 Rest of Europe Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 19 Japan Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 20 China Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 21 Rest of Asia Pacific Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 22 Brazil Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 23 Mexico Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 24 Rest of Latin America Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 25 GCC Organ on Chip Market, 2016 – 2026 (US$ Mn)
FIG. 26 Rest of Middle East and Africa Organ on Chip Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Organ on Chip Market Portraiture
TABLE 2 Global Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 4 North America Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 5 North America Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 6 North America Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 7 Europe Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 13 Latin America Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 16 Middle East and Africa Organ on Chip Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa Organ on Chip Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa Organ on Chip Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 19 Ascendance Biotechnology: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 CN Bio Innovations: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Emulate, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 HµREL Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Insphero AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 MIMETAS B.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Nortis Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 TARA Biosystems, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 TissUse GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)